The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Diagnostic features of atopic dermatitis

Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086 · see citing works

The Design and Analysis of Clinical Experiments

Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819 · see citing works

Severe Psoriasis – Oral Therapy with a New Retinoid

Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718 · see citing works

Severity Scoring of Atopic Dermatitis: The SCORAD Index

(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,282 · see citing works

Large sample standard errors of kappa and weighted kappa.

Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,542 · see citing works

Grading of the severity of atopic dermatitis.

Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415 · see citing works

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411 · see citing works

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329 · see citing works

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323 · see citing works

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy

Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285 · see citing works

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

Luger, T. A., van Leent, E. J. M., Graeber, M., Hedgecock, S., Thurston, M., Kandra, A., Berth‐Jones, J., Bjerke, J. R., Christophers, E., KNOP, J., et al. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04134.x · Cited by 240 · see citing works

Clinical effects of diaper types on the skin of normal infants and infants with atopic dermatitis

Seymour, J. L., Keswick, B. H., Hanifin, J. M., Jordan, W. P., & Milligan, M. C. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70288-6 · Cited by 148 · see citing works

Scoring atopic dermatitis: the simpler the better?

Costa, C., Rilliet, A., Nicolet, M., & Saurat, J. ‐. (1989) · PubMed · Cited by 140 · see citing works

Disease Severity Measures in a Population of Psoriasis Patients: The Symptoms of Psoriasis Correlate With Self-Administered Psoriasis Area Severity Index Scores

Fleischer, A. B., Feldman, S. R., Rapp, S. R., Reboussin, D. M., Exum, M. L., Clark, A. R., & Rajashekhar, V. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12297659 · Cited by 97 · see citing works

Quantification of the Extent and the Severity of Atopic Dermatitis: The ADASI Score

Bahmer, F. A. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680070141025 · Cited by 53 · see citing works

Standardized grading of subjects for clinical research studies in atopic dermatitis: workshop report.

Jm, H. (1989) · PubMed · doi:10.2340/000155551442830 · Cited by 36 · see citing works

Atopic dermatitis: elements in clinical study design and analysis.

ABRAMS, B. B. (1989) · PubMed · doi:10.2340/000155551441519 · Cited by 5 · see citing works

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110 · see citing works

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M. H., Bieber, T. R. M., Rocklin, R. E., Ming, J. E., Ren, H., Kao, R., Simpson, E. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,415 · see citing works

Guidelines of care for the management of atopic dermatitis

Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,305 · see citing works

Epidemiology of atopic dermatitis in adults: Results from an international survey

Barbarot, S., Auzière, S., Gadkari, A., Girolomoni, G., Puig, L., Simpson, E. L., Margolis, D. J., de Bruin-Weller, M. S., & Eckert, L. (2018) · Allergy · doi:10.1111/all.13401 · Cited by 890 · see citing works

Targeting key proximal drivers of type 2 inflammation in disease

Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766 · see citing works

Tight junction defects in patients with atopic dermatitis

Benedetto, A. D., Rafaels, N. M., McGirt, L. Y., Ivanov, A. I., Georas, S. N., Cheadle, C., Berger, A. E., Zhang, K., Vidyasagar, S., Yoshida, T., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.018 · Cited by 750 · see citing works

The Patient-Oriented Eczema Measure

Charman, C. R., Venn, A. J., & Williams, H. C. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.12.1513 · Cited by 660 · see citing works

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592 · see citing works

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Thaçi, D., Simpson, E. L., Beck, L. A., Bieber, T. R. M., Blauvelt, A., Papp, K. A., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H. L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 573 · see citing works

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30732-7 · Cited by 522 · see citing works

Toward a new generation of smart skins

Someya, T., & Amagai, M. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0079-1 · Cited by 485 · see citing works

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Bieber, T. R. M., Simpson, E. L., Silverberg, J. I., Thaçi, D., Paul, C. F., Pink, A., Kataoka, Y., Chu, C., DiBonaventura, M., Rojo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2019380 · Cited by 481 · see citing works

Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity

Huang, J. T., Abrams, M., Tlougan, B. E., RADEMAKER, A. W., & Paller, A. S. (2009) · PEDIATRICS · doi:10.1542/peds.2008-2217 · Cited by 478 · see citing works

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Hamilton, J. D., Suárez‐Fariñas, M., Dhingra, N., Cardinale, I. R., Li, X., Kostić, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N. M. H., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 472 · see citing works

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Silverberg, J. I., Simpson, E. L., Thyssen, J. P., Gooderham, M., Chan, G. L., Feeney, C., Biswas, P., Valdez, H., DiBonaventura, M., Nduaka, C. I., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1406 · Cited by 413 · see citing works

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis

Yosipovitch, G., Reaney, M. D., Mastey, V., Eckert, L., Abbé, A., Nelson, L. M., Clark, M., Williams, N., Chen, Z., Ardeleanu, M., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17744 · Cited by 405 · see citing works

Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children

Wahn, U., Bos, J. D., Goodfield, M. J. D., Caputo, R., Papp, K. A., Manjra, A. I., DOBOZY, A., Paul, C. F., Molloy, S., Hultsch, T., et al. (2002) · PEDIATRICS · doi:10.1542/peds.110.1.e2 · Cited by 402 · see citing works

Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children

Lynch, S. V., Wood, R. A., Boushey, H. A., Bacharier, L. B., Bloomberg, G. R., Kattan, M., O’Connor, G. T., Sandel, M. T., Calatroni, A., Matsui, E. C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.018 · Cited by 392 · see citing works

Barrier Function and Water-Holding and Transport Properties of Infant Stratum Corneum Are Different from Adult and Continue to Develop through the First Year of Life

Nikolovski, J., Stamatas, G. N., Kollias, N., & Wiegand, B. C. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701239 · Cited by 388 · see citing works

What are the best outcome measurements for atopic eczema? A systematic review

Schmitt, J., Langan, S., & Williams, H. C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.011 · Cited by 388 · see citing works

Guidelines of care for atopic dermatitis

Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.08.003 · Cited by 388 · see citing works

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

Eichenfield, L. F., Lucky, A. W., Boguniewiczc, M., Langley, R. G. B., Cherille, R., Marshalle, K., Bushe, C., & Graeber, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122187 · Cited by 364 · see citing works

Atopic Dermatitis: Natural History, Diagnosis, and Treatment

Thomsen, S. F. (2014) · ISRN Allergy · doi:10.1155/2014/354250 · Cited by 356 · see citing works

Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 354 · see citing works

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial

Guttman-Yassky, E., Blauvelt, A., Eichenfield, L. F., Paller, A. S., Armstrong, A. W., Drew, J., Gopalan, R., & Simpson, E. L. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0079 · Cited by 341 · see citing works

Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection

Fishbein, A. B., Silverberg, J. I., Wilson, E. J., & Ong, P. Y. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.06.044 · Cited by 336 · see citing works

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

Nakatsuji, T., Hata, T. R., Tong, Y., Cheng, J. Y., Shafiq, F., Butcher, A. M., Salem, S. S., Brinton, S. L., Rudman Spergel, A. K., Johnson, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01256-2 · Cited by 333 · see citing works

The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

Schmitt, J., Spuls, P. I., Thomas, K. S., Simpson, E., Furue, M., Deckert, S., Dohil, M., Apfelbacher, C., Singh, J. A., Chalmers, J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.043 · Cited by 319 · see citing works

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

Guttman‐Yassky, E., Silverberg, J. I., Nemoto, O., Forman, S. B., Wilke, A. V., Prescilla, R. P., de la Peña, A., Nunes, F. P., Janes, J., Gamalo, M., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.01.018 · Cited by 319 · see citing works

Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape

Boguniewicz, M., Fonacier, L. S., Guttman‐Yassky, E., Ong, P. Y., Silverberg, J. I., & Farrar, J. R. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.10.039 · Cited by 308 · see citing works

Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial

Gong, J. Q., Lin, L., Lin, T., Hao, F., Zeng, F. Q., Bi, Z., Yi, D., & Zhao, B. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07410.x · Cited by 307 · see citing works

Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults

Simpson, E. L., Bieber, T. R. M., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., & Mastey, V. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.10.043 · Cited by 303 · see citing works

Severity strata for Eczema Area and Severity Index ( EASI ), modified EASI , Scoring Atopic Dermatitis ( SCORAD ), objective SCORAD , Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis

Chopra, R., Vakharia, P. P., Sacotte, R. M., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., & Silverberg, J. I. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15641 · Cited by 302 · see citing works

Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation

Schmitt, J. M., Langan, S., Deckert, S., Svensson, Å., von Kobyletzki, L., Thomas, K. S., & Spuls, P. I. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.008 · Cited by 295 · see citing works

The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability

Held, E., Skoet, R., Johansen, J. D., & Agner, T. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06305.x · Cited by 291 · see citing works

Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency

Kežić, S., O’Regan, G. M., Lutter, R., Jakaša, I., Koster, E. S., Saunders, S. P., Caspers, P. J., Kemperman, P. M. J. H., Puppels, G. J., Sandilands, A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.989 · Cited by 276 · see citing works

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug

Kapp, A., Papp, K. A., Bingham, A., Fölster‐Holst, R., Ortonne, J. P., Potter, P. C., Gulliver, W. P. F., Paul, C. F., Molloy, S., Barbier, N., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126500 · Cited by 270 · see citing works

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

Wollenberg, A., Reitamo, S., Atzori, F., Lahfa, M., Ruzicka, T., Healy, E., Giannetti, A., Bieber, T. R. M., Vyas, J., Deleuran, M. S., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01683.x · Cited by 266 · see citing works

Guidelines for management of atopic dermatitis

Saeki, H., Furue, M., Furukawa, F., Hide, M., Ohtsuki, M., Katayama, I., 佐々木, り., Suto, H., & Takehara, K. (2009) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00706.x · Cited by 266 · see citing works

Emollients and moisturisers for eczema

van Zuuren, E. J., Fedorowicz, Z., Christensen, R., Lavrijsen, A. P. M., & Arents, B. W. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012119.pub2 · Cited by 266 · see citing works

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum

Beck, L. A., Boguniewicz, M., Hata, T. R., Schneider, L. C., Hanifin, J. M., Gallo, R. L., Paller, A. S., Lieff, S., Reese, J., Zaccaro, D. J., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.020 · Cited by 261 · see citing works

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe: PO-SCORAD self-assessment scale validation

Stalder, J.-F., Barbarot, S., Wollenberg, A., Holm, E. A., De Raeve, L., Seidenari, S., Oranje, A., Deleuran, M., Cambazard, F., Svensson, A., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02577.x · Cited by 255 · see citing works

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

Reitamo, S., Rustin, M. H. A., Ruzicka, T., Cambazard, F., Kalimo, K., Friedmann, P. S., Schoepf, E., Lahfa, M., Diepgen, T. L., Judodihardjo, H., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121832 · Cited by 254 · see citing works

Anti-CD20 (rituximab) treatment improves atopic eczema

Simon, D., Radonjic‐Hoesli, S., Kostylina, G., Yawalkar, N., & Simon, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.016 · Cited by 253 · see citing works

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Kaino, H., & Nagata, T. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.12.015 · Cited by 242 · see citing works

Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum

Gao, P.-S., Rafaels, N. M., Hand, T. A., Murray, T., Boguniewicz, M., Hata, T. R., Schneider, L. C., Hanifin, J. M., Gallo, R. L., Gao, L., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.034 · Cited by 242 · see citing works

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis

Reitamo, S., van Leent, E. J. M., Ho, V., Harper, J. I., Ruzicka, T., Kalimo, K., Cambazard, F., Rustin, M. H. A., Taı̈eb, A., Gratton, D., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121831 · Cited by 236 · see citing works

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

Hedin, C. R. H., Vavricka, S., Stagg, A. J., Schoepfer, A. M., Raine, T., Puig, L., Pleyer, U., Navarini, A. A., Jong, A. E. V. D. M., Maul, J., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy191 · Cited by 232 · see citing works

Burden of skin pain in atopic dermatitis

Vakharia, P. P., Chopra, R., Sacotte, R. M., Patel, K. R., Singam, V., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., et al. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.09.076 · Cited by 222 · see citing works

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.053 · Cited by 220 · see citing works

Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study

Meurer, M., Fölster‐Holst, R., Wozel, G., Weidinger, G., Jünger, M., Bräutigam, M., & f for the CASM-DE-01 Study Group (2002) · Dermatology · doi:10.1159/000065863 · Cited by 219 · see citing works

The Eczema Area and Severity Index – a practical guide

Hanifin, J. M., Baghoomian, W., Grinich, E., Leshem, Y. A., Jacobson, M., & Simpson, E. L. (2022) · Dermatitis · doi:10.1097/der.0000000000000895 · Cited by 213 · see citing works

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

Faiz, S., Giovannelli, J., Podevin, C., Jachiet, M., Bouaziz, J.-D., Reguiai, Z., Nosbaum, A., Lasek, A., Ferrier le Bouedec, M.-C., Du Thanh, A., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.02.053 · Cited by 210 · see citing works

Japanese guidelines for atopic dermatitis 2020

Katoh, N., Ohya, Y., Ikeda, M., Ebihara, T., Katayama, I., Saeki, H., Shimojo, N., Tanaka, A., Nakahara, T., Nagao, M., et al. (2020) · Allergology International · doi:10.1016/j.alit.2020.02.006 · Cited by 205 · see citing works

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants

Ho, V. C., Gupta, A. K., Kaufmann, R., Todd, G., Vanaclocha, F., Takaoka, R., Fölster‐Holst, R., Potter, P., Marshall, K., Thurston, M., et al. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.65 · Cited by 199 · see citing works

Topical tacrolimus for atopic dermatitis

Cury‐Martins, J., Martins, C. R., Aoki, V., de Góis, A. F. T., Ishii, H. A., & da Silva, E. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009864.pub2 · Cited by 197 · see citing works

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

Guttman‐Yassky, E., Simpson, E. L., Reich, K., Kabashima, K., Igawa, K., Suzuki, T., Mano, H., Matsui, T., Esfandiari, E., & Furue, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02037-2 · Cited by 190 · see citing works

Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine

Bieber, T. (2012) · Allergy · doi:10.1111/all.12049 · Cited by 188 · see citing works

Atopic Dermatitis and Fungi

Faergemann, J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.545-563.2002 · Cited by 187 · see citing works

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Simpson, E. L., Bissonnette, R., Eichenfield, L. F., Guttman‐Yassky, E., King, B., Silverberg, J. I., Beck, L. A., Bieber, T. R. M., Reich, K., Kabashima, K., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.104 · Cited by 185 · see citing works

Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis

Ishiuji, Y., Coghill, R. C., Patel, T. S., Oshiro, Y., Kraft, R., & Yosipovitch, G. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09308.x · Cited by 176 · see citing works

Disease severity, scratching, and sleep quality in patients with atopic dermatitis

Bender, B. G., Ballard, R., Canono, B. P., Murphy, J. R., & Leung, D. Y. M. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.10.010 · Cited by 176 · see citing works

Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children

Camargo, C. A., Ganmaa, D., Sidbury, R., Erdenedelger, K., Radnaakhand, N., & Byamba, K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.002 · Cited by 175 · see citing works

Association between obesity and atopic dermatitis in childhood: A case-control study

Silverberg, J. I., Kleiman, E., Lev‐Tov, H. A., Silverberg, N. B., Durkin, H. G., Joks, R. O., & Smith-Norowitz, T. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.063 · Cited by 171 · see citing works

Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K., Sugaya, M., Murota, H., Ebihara, T., Kataoka, Y., Aihara, M., Etoh, T., et al. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13392 · Cited by 171 · see citing works

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

Eichenfield, L. F., Flohr, C., Sidbury, R., Siegfried, E. C., Szalai, Z. Z., Galus, R., Yao, Z., Takahashi, H., Barbarot, S., Feeney, C., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.2830 · Cited by 170 · see citing works

Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010

Rehal, B., & Armstrong, A. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017520 · Cited by 168 · see citing works

A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis

Peppers, J., Paller, A. S., Maeda-Chubachi, T., Wu, S., Robbins, K., Gallagher, K., & Kraus, J. E. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.047 · Cited by 165 · see citing works

IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis

Horikawa, T. (2002) · International Immunology · doi:10.1093/intimm/dxf044 · Cited by 165 · see citing works

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Blauvelt, A., Silverberg, J. I., Lynde, C. W., Bieber, T. R. M., Eisman, S., Zdybski, J., Gubelin, W., Simpson, E. L., Valenzuela, F., Criado, P. R., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.05.075 · Cited by 164 · see citing works

Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

Simpson, E. L., Gadkari, A. S., Worm, M., Soong, W., Blauvelt, A., Eckert, L., Wu, R., Ardeleanu, M., Graham, N. M. H., Pirozzi, G., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.054 · Cited by 161 · see citing works

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Chalmers, J. R., Thomas, K. S., Apfelbacher, C., Williams, H. C., Prinsen, C. A. C., Spuls, P. I., Simpson, E., Gerbens, L. A. A., Boers, M., Barbarot, S., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16543 · Cited by 160 · see citing works

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

Peserico, A., Städtler, G., Sebastian, M., Suárez‐Fernández, R., Vick, K., & Bieber, T. R. M. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08436.x · Cited by 159 · see citing works

Measuring Atopic Dermatitis Severity in Randomized Controlled Clinical Trials: What Exactly Are We Measuring?

Charman, C. R., Chambers, C., & Williams, H. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12251.x · Cited by 159 · see citing works

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme

Barbier, N., Paul, C. F., Luger, T. A., Allen, R., Prost, Y. D., Papp, K. A., Eichenfield, L. F., Cherill, R., & Hanifin, J. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05696.x · Cited by 154 · see citing works

CCL18 Is Expressed in Atopic Dermatitis and Mediates Skin Homing of Human Memory T Cells

Günther, C., Bello-Fernández, C., Kopp, T., Kund, J., Carballido‐Perrig, N., Hinteregger, S., Fassl, S., Schwärzler, C., Lametschwandtner, G., Stingl, G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1723 · Cited by 153 · see citing works

The Objective Severity Assessment of Atopic Dermatitis Score

Sugarman, J. L., Fluhr, J. W., Fowler, A. J., Bruckner, T., Diepgen, T. L., & Williams, M. L. K. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1417 · Cited by 152 · see citing works

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies

Paller, A. S., Lebwohl, M., Fleischer, A. B., Antaya, R. J., Langley, R. G. B., Kirsner, R. S., Blum, R. R., Rico, M. J., Jaracz, E., Crowe, A. W., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.12.038 · Cited by 151 · see citing works

What causes itch in atopic dermatitis?

Yosipovitch, G., & Papoiu, A. D. P. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0049-z · Cited by 150 · see citing works

Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies

Kim, H., Lee, J. H., Roh, K.-H., Jun, H. J., Kang, K., & Kim, T. (2016) · Stem Cells · doi:10.1002/stem.2401 · Cited by 150 · see citing works

Reliability of Clinician Erythema Assessment grading scale

Tan, J. K. L., Liu, H., Leyden, J. J., & Leoni, M. J. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.044 · Cited by 149 · see citing works

Increased serum levels of interleukin 33 in patients with atopic dermatitis

Tamagawa‐Mineoka, R., Okuzawa, Y., Masuda, K., & Katoh, N. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.01.867 · Cited by 149 · see citing works

Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

Paller, A. S., Flohr, C., Cork, M. J., Bewley, A., Blauvelt, A., Hong, H., Imafuku, S., Schuttelaar, M. L. A., Simpson, E. L., Soong, W., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.0627 · Cited by 148 · see citing works

Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study

Nakagawa, H., Nemoto, O., Igarashi, A., & Nagata, T. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16014 · Cited by 145 · see citing works

First experience of topical SDZ ASM 981 in children with atopic dermatitis

Harper, J. I., Green, A., Scott, G., Gruendl, E., Dorobek, B., Cardno, M., & Burtin, P. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04133.x · Cited by 144 · see citing works

Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection

Navarini, A. A., French, L. E., & Hofbauer, G. F. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.009 · Cited by 140 · see citing works

Therapeutic responses to <i>Roseomonas mucosa</i> in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair

Myles, I. A., Castillo, C. R., Barbian, K. D., Kanakabandi, K., Virtaneva, K., Fitzmeyer, E., Paneru, M., Otaizo-Carrasquero, F., Myers, T. G., Markowitz, T. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8631 · Cited by 139 · see citing works

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Werfel, T., Layton, G. R., Yeadon, M., Whitlock, L. A., Osterloh, I. H., Jimenez, P. A., Liu, W. M., Lynch, V., Asher, A., Tsianakas, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.047 · Cited by 138 · see citing works

Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis

Silverberg, J. I., Thyssen, J. P., Fahrbach, K. R., Mickle, K., Cappelleri, J. C., Romero, W., Cameron, M. C., Myers, D. E., Clibborn, C., & DiBonaventura, M. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17351 · Cited by 138 · see citing works

Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects

Jakaša, I., de Jongh, C. M., Verberk, M. M., Bos, J. D., & Kežić, S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07319.x · Cited by 137 · see citing works

Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown

Ogonowska, P., Gilaberte, Y., Barańska‐Rybak, W., & Nakonieczna, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567090 · Cited by 137 · see citing works

Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis

Hanifin, J. M., Paller, A. S., Eichenfield, L. F., Clark, R. A. F., Korman, N. J., Weinstein, G. D., Caro, I., Jaracz, E., & Rico, M. J. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.04.062 · Cited by 136 · see citing works

Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial

Ibler, K. S., Jemec, G. B. E., Diepgen, T. L., Gluud, C. N., Hansen, J. L., Winkel, P., Thomsen, S. F., & Agner, T. (2012) · BMJ · doi:10.1136/bmj.e7822 · Cited by 135 · see citing works

Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H4R‐antagonist ( JNJ ‐39758979) in J apanese adults with moderate atopic dermatitis

Murata, Y., Song, M., Kikuchi, H., Hisamichi, K., Xu, X. L., Greenspan, A. J., Kato, M., Chiou, C., Kato, T., Guzzo, C. A., et al. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12726 · Cited by 133 · see citing works

Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis

Batista, D. I. S., Perez, L., Orfali, R. L., Zaniboni, M. C., ­Samorano, L. P., Pereira, N. V., Sotto, M. N., Ishizaki, A. S., Oliveira, L. M. D. S., Sato, M. N., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12753 · Cited by 132 · see citing works

Clinical practice guidelines for the management of atopic dermatitis 2018

Katoh, N., Ohya, Y., Ikeda, M., Ebihara, T., Katayama, I., Saeki, H., Shimojo, N., Tanaka, A., Nakahara, T., Nagao, M., et al. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15090 · Cited by 131 · see citing works

The burden of atopic dermatitis in US adults: results from the 2013 National Health and Wellness Survey

Whiteley, J., Emir, B., Seitzman, R., & Makinson, G. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1195733 · Cited by 130 · see citing works

A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis

Reitamo, S., Ortonne, J. ‐., Sand, C., Cambazard, F., Bieber, T. R. M., Fölster‐Holst, R., Vena, G., Bos, J. D., Fabbri, P., Larsen, C. G., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06592.x · Cited by 130 · see citing works

Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics

Mansouri, Y., & Guttman‐Yassky, E. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050858 · Cited by 128 · see citing works

0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial

Reitamo, S., Harper, J. I., Bos, J. D., Cambazard, F., Bruijnzeel-Koomen, C. A. F. M., van der Valk, P. G. M., Smith, C. H., Moss, C., DOBOZY, A., Palatsi, R., et al. (2004) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2004.05782.x · Cited by 128 · see citing works

Interobserver Agreement of the Eczema Area and Severity Index for Atopic Dermatitis Severity Assessment: A Real-World Evidence Study

Villa-González, J. M., Gonzalez-Hermosa, M. R., Alzaga, J. U., Blasco, R. P., Ibarrola, P. A., Atxutegi‐Ayesta, X., García, A. G., Aguirre, I. I., del Tánago, B. U. G., Ares, M. P., et al. (2025) · Dermatitis · doi:10.1089/derm.2025.0054 · Cited by 2 · see citing works

What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study

Leshem, Y. A., Hajar, T., Hanifin, J. M., & Simpson, E. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13662 · Cited by 295 · see citing works

How Adequately is the Severity of Atopic Dermatitis Assessed by Resident Physicians Training in Dermatology? Evaluation of the Intrarater and Interrater Reliability of Clinical Scoring Systems (EASI, oSCORAD, IGA, TIS Score, SASSAD)

Waligóra-Dziwak, K., Kubiak, K. B., Dańczak‐Pazdrowska, A., & Jenerowicz, D. (2026) · Acta Dermato Venereologica · doi:10.2340/actadv.v106.43964 · Cited by 1 · see citing works

Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA

Bożek, A., & Reich, A. (2017) · Dermatology · doi:10.1159/000472711 · Cited by 74 · see citing works

The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis

Baek, J. H., Park, C. W., Choi, K. M., Yang, Y. S., Lee, S. Y., Koh, J. S., Chung, B. Y., Kim, H. O., & Park, G. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12711 · Cited by 11 · see citing works